FDA Criminal Defense FAQ

Answers to Common Questions About FDA Adulteration, Misbranding, and FDCA Prosecutions – FDA Criminal Defense FAQ

What is an FDA criminal case?

An FDA criminal case is a federal prosecution brought under the Federal Food, Drug, and Cosmetic Act (FDCA). These matters are pursued by the government when it alleges that a drug, medical device, or regulated product was adulterated or misbranded, or that a prohibited act occurred in interstate commerce.

Unlike civil or administrative enforcement, FDA criminal cases carry real criminal exposure—felony convictions, incarceration, devastating fines, and long-term professional consequences. For physicians, executives, and regulated businesses, the stakes are existential.

 

What statutes are used in FDA criminal prosecutions?

The government most commonly relies on broad FDCA provisions, including:

• 21 U.S.C. § 331 – Prohibited acts under the FDCA
  
• 21 U.S.C. § 351 – Adulterated drugs and medical devices
  
• 21 U.S.C. § 352 – Misbranded drugs and medical devices
  
• 18 U.S.C. § 1347 – Health care fraud (frequently added in clinical or billing-related cases)

Critically, some of these statutes do not require proof of intent, deception, or patient harm—an issue that lies at the heart of many FDA criminal defense strategies.

 

Who investigates FDA criminal cases?

FDA criminal cases are primarily investigated by the FDA Office of Criminal Investigations (FDA-OCI). These agents are armed federal law enforcement officers, not compliance inspectors, and they often work alongside:

• U.S. Attorney’s Offices
  
• The Department of Justice Consumer Protection Branch
  
• HHS Office of Inspector General (HHS-OIG)
  
• The FBI in select cases

When FDA-OCI becomes involved, the matter has crossed from regulatory oversight into criminal enforcement.

 

How do FDA criminal investigations usually begin?

Many FDA criminal investigations begin quietly, often disguised as routine inspections or compliance reviews. Common triggers include:

• FDA inspections or repeat follow-up inspections
  
• Whistleblower or employee complaints
  
• Adverse event reports
  
• Billing audits that expand into regulatory scrutiny
  
• Tips from competitors or former employees

Targets are frequently unaware the investigation has become criminal until subpoenas are issued or products and records are seized.

 

What is FDA “adulteration”?

Under 21 U.S.C. § 351, a product may be deemed adulterated if it was manufactured, prepared, packed, or held under conditions the government claims failed to meet FDA requirements. Importantly, the government does not need to prove that a patient was injured or harmed.

In criminal cases, adulteration allegations often focus on sterilization protocols, storage conditions, device handling, or quality system requirements.

 

What is FDA “misbranding”?

Misbranding under 21 U.S.C. § 352 typically involves allegations that labeling, instructions, or warnings were false, misleading, or inadequate. In practice, these cases frequently hinge on regulatory interpretation rather than fraud or intentional deception.

 

Do FDA criminal cases require proof of patient harm?

Often, no. Many FDCA criminal charges are based on alleged regulatory violations or theoretical risk—not actual patient injury. This controversial feature of FDA criminal enforcement is a central focus of high-level defense strategy.

 

Can doctors and healthcare providers be charged under the FDCA?

Yes. Physicians, clinic owners, and healthcare providers may face FDA criminal charges, particularly where the government alleges improper device handling, sterilization failures, or off-label use. These cases raise serious concerns about criminalizing medical judgment rather than punishing true misconduct.

 

What role do CDC or medical board guidelines play in FDA criminal defense?

Guidance from the Centers for Disease Control and Prevention (CDC) and approval by state medical boards can be powerful defenses. Many FDA prosecutions involve conduct that:

• Followed CDC-approved sterilization or disinfection protocols
  
• Was inspected and approved by state licensing authorities
  
• Reflected accepted professional or industry standards

When federal prosecutors attempt to override regulatory or professional approval, those conflicts become fertile ground for dismissal or acquittal.

 

What are common defenses to FDA adulteration and misbranding charges?

Effective FDA criminal defense often includes:

• Demonstrating compliance with CDC or FDA guidance
  
• Establishing the absence of patient harm
  
• Challenging whether products were actually “held for sale”
  
• Exposing speculative or unsupported expert opinions
  
• Showing approval by licensing or oversight bodies
  
• Revealing regulatory disagreements improperly framed as crimes

 

What is the FDA–DOJ “strike force” model?

The DOJ has increasingly embedded FDA-OCI agents directly with prosecutors, accelerating the criminalization of FDCA matters. This strike-force approach means investigations escalate faster—and regulated professionals face criminal exposure earlier than ever before.

 

Are FDA criminal cases strict-liability offenses?

In many contexts, yes. Certain FDCA offenses do not require proof of intent. Good faith, lack of knowledge, or absence of harm may not prevent charges—making early, aggressive defense intervention critical.

 

What are Brady and Giglio issues in FDA cases?

FDA prosecutions frequently involve discovery violations, including:

• Brady v. Maryland failures to disclose exculpatory evidence
  
• Giglio v. United States failures to disclose impeachment material
  
• Jencks Act (18 U.S.C. § 3500) violations
  
• Failure to preserve investigator communications

These issues can support motions to dismiss, mistrial requests, or appellate relief.

 

Should I speak to FDA-OCI agents without a lawyer?

No. FDA-OCI agents are criminal investigators—not compliance advisors. Anything you say can and will be used against you. You should consult experienced FDA criminal defense counsel before any interview, statement, or written response.

 

When should I contact an FDA criminal defense attorney?

You should seek counsel immediately if:

• FDA-OCI agents contact you
  
• Your facility is subjected to repeated or aggressive inspections
  
• Devices, products, or records are seized
  
• You receive subpoenas or target letters
  
• DOJ prosecutors become involved

Early representation can prevent charges or significantly narrow exposure.

 

What penalties can result from FDA criminal convictions?

Penalties may include:

• Felony convictions
  
• Prison sentences
  
• Substantial fines and forfeiture
  
• Loss of medical or professional licenses
  
• Exclusion from federal healthcare programs

In many cases, the collateral consequences far exceed the criminal sentence itself.

 

Why are FDA criminal cases increasing?

FDA criminal enforcement has expanded as part of a broader DOJ strategy emphasizing aggressive prosecution of regulatory violations. Critics warn this reflects a troubling trend toward overcriminalization of healthcare and regulatory compliance.

 

What makes FDA criminal defense different from other white-collar cases?

FDA criminal defense demands deep, interdisciplinary expertise, including:

• Federal criminal law
  
• Regulatory and administrative law
  
• Medical and scientific evidence
  
• Expert witness cross-examination
  
• FDCA statutory interpretation

These are not ordinary white-collar cases—they require seasoned, specialized counsel.

 

What should I do right now if I’m concerned about FDA criminal exposure?

Preserve documents, do not communicate with investigators without counsel, and consult an experienced FDA criminal defense attorney immediately. Early action—guided by strategic, high-level defense—can fundamentally change the trajectory of the case.

 

 

FDA Charges Guides

• FDA Authority vs. Medical Practice
• FDA Criminal Defense FAQ
• Defending FDA Criminal Cases
• The DOJ-FDA Strike Force
• FDA Adulteration and Misbranding Charges